80
Participants
Start Date
February 1, 2022
Primary Completion Date
March 1, 2024
Study Completion Date
June 1, 2025
Sub-phenotyping by biomarkers concentration
Plasma will be collected at ICU admission (i.e., \< 6 hours from graft reperfusion), centrifuged (1500G for 15 min), frozen at -80°c, and then centralized at the Institutional laboratory. The following biomarkers will be assessed: Interleukin-1β, Interleukin-2, Interleukin-6, Interferon-γ, Tumor Necrosis Factor-alpha (TNF-α), chemokine (C-C motif) ligand-2 (CCL-2), Interleukin-15 (IL-15), Ferritin, and D-dimer, by a point-of-care biochip-array device (RANDOX, Multistat)
Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico, Milan
University of Milan
OTHER
Policlinico Hospital
OTHER